Larvol Delta - SPANPD-Subgroup-analyses-by-baseline-characteristics-of-patients-treated-with-levodopa-inhalation-powder-84-mg-or-placebo-to-treat-OFF-symptoms-in-patients-with-Parkinson39s-disease-PD

Inbrija (levodopa inhalation powder) - Acorda

https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mdc3.13411

S. Isaacson; P. Zhao; B. Blank

Jun 24, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next